Last reviewed · How we verify
Shensong Yangxin Capsule in the Treatment of Mild to Moderate Systolic Heart Failure Complicated With Ventricular Premature Beat: A Randomize, Double Blind, Placebo-controlled Multicenter Clinical Trial
The purpose of this study is to assess the effects of Chinese medicine Shensong Yangxin capsule for the chronic cardiac dysfunction complicated with ventricular premature beats.
Details
| Lead sponsor | Cong-xin Huang |
|---|---|
| Phase | Phase 4 |
| Status | UNKNOWN |
| Enrolment | 460 |
| Start date | 2012-09 |
| Completion | 2013-12 |
Conditions
- Heart Failure
- Ventricular Premature Complex
Interventions
- Shensong Yangxin capsule
- placebo Capsule
Primary outcomes
- numbers of the Premature ventricular contractions during 24-hour ambulatory ECG — 3 months
Countries
China